Objective: To study dietary intake and serum concentrations of isoflavones in order to provide relative validation of isoflavone intake estimates from the Scottish Collaborative Group -Food-Frequency Questionnaire (SCG-FFQ). Design: Validation study. Setting: Southern Scotland. Method: Dietary intake of isoflavones was estimated using the semiquantitative SCG-FFQ and rank correlation and Kappa statistics were used for the relative validation of intakes against serum isoflavone concentrations in 203 male participants who were population controls in a case-control study of diet and prostate cancer. Results: The median intake of isoflavones (daidzein and genistein) was 1.0 mg/day (I-QR 0.6-1.8). The median serum concentration of genistein was 33.79 nmol/l (I-QR 14.12-64.93), nearly twice that of daidzein (18.00 nmol/l, I-QR 8.26-29.45). Equol was detected in 49% of subjects; in these subjects the median was 0.67 nmol/l (I-QR 0.34-1.51). Isoflavone intake was significantly correlated with serum concentrations of daidzein (r ¼ 0.24, P ¼ 0.001), genistein (r ¼ 0.26, Po0.001) and total isoflavonoids (sum of daidzein, genistein and equol) (r ¼ 0.27, Po0.001). Whereas values for weighted Kappa ranged from 0.16 (P ¼ 0.002) for daidzein and equol combined to 0.22 (Po0.001) for genistein.
Introduction
The relatively low risk of mortality in hormone dependant cancers, especially prostate cancer (PCa), in Asian populations compared to Western countries suggest that certain dietary factors may influence the prevalence of and mortality from these diseases (Armstrong and Doll, 1975; Muir et al., 1991; Parkin and Muir, 1992; Maskarinec et al., 1998) . Of special interest is the group of plant-derived nutrients called phyto-oestrogens, in particular isoflavones.
The relevant biological properties of isoflavones include antiviral, antiangiogenic and antioxidant properties (Griffiths et al., 1998) . Isoflavones possess weak oestrogenic activity, they compete with oestradiol for binding to the nuclear oestrogen receptor and also stimulate the synthesis of sex hormone binding globulin (SHGB), which in turn mediates the plasma levels of testosterone on which the growth, development, maintenance and function of the prostate gland is dependent. In addition, isoflavones can inhibit steroid metabolising enzymes, including 5a-reductase and aromatase, and also cell-signalling apparatus by the inhibition of tyrosinespecific protein kinases (Griffiths et al., 1998) .
Isoflavones are found mainly in soybeans and soy products (Coward et al., 1993; Kuzer and Xu, 1997; Mazur, 1998; Murphy et al., 1999) , foods that are consumed daily in considerable amounts by populations in Asia (Chen et al., 1999; Wakai et al., 1999) , providing average isoflavone intakes of 30-46 mg/day (Seow et al., 1998; Chen et al., 1999; Arai et al., 2000) . In Western countries, soy foods tend to be eaten most frequently by vegetarians and vegans. Several epidemiological studies support the role of isoflavones and other phyto-oestrogens in reducing cancer risk (Adlercreutz and Mazur, 1997) .
The assessment of the dietary intake of isoflavones and their respective plasma/serum concentrations and urinary excretions within Chinese and Japanese populations and ethnic groups has been extensively reported (Maskarinec et al., 1998; Seow et al., 1998; Chen et al., 1999; Arai et al., 2000; Huang et al., 2000; Uehara et al., 2000; Yamamoto et al., 2001) . However, the valid assessment of isoflavone intake in populations which eat few soy products has been a greater challenge, which various groups in the US (Atkinson et al., 2002; Frankenfeld et al., 2002 Frankenfeld et al., , 2003 and UK (Verkasalo et al., 2001; Ritchie et al., 2004a) have recently sought to address. Ritchie et al. (2004a) analysed duplicate diets and both plasma and urinary isoflavone concentrations to validate the new Isoflavone Food Database (Ritchie, 2004) . The current investigation addresses the validation of isoflavone intake assessment using the SCG-FFQ (Scottish Collaborative Group -Food-Frequency Questionnaire), which incorporates the new Isoflavone Food Database (Ritchie, 2004; Ritchie et al., 2005) , in a larger population of older men.
The first aim of this study was to define the distributions of the estimated dietary intake of isoflavones and serum concentrations of the main isoflavones daidzein and genistein and the isoflavan equol in older men, participating as population controls in the PCANDIET study, a case-control study of PCa, inherited susceptibility and diet. The second aim was to determine whether the level of isoflavone intake, estimated by the SCG-FFQ, was associated with serum concentrations of isoflavones. A significant positive association between intake and serum values of isoflavones will serve to validate the use of the SCG-FFQ in ranking intake levels of isoflavones in the study population.
Methods

Subjects
Subjects were male, aged between 50 and 74 years, who participated as population controls in the PCANDIET Study, a case-control study of PCa, inherited susceptibility and diet. The volunteers were recruited at random through the Borders and Lothian Health Board lists and from patient lists of general practitioners (GPs) within the Greater Glasgow Health Board area, and resided in the Borders, Lothian and Greater Glasgow Health Board areas of Scotland. After providing informed written consent to take part in the study, the subjects were asked to complete the SCG-FFQ and to provide a nonfasting blood sample.
All subjects who returned their fully completed SCG-FFQ and whose blood sample had been analysed for isoflavone serum concentrations were included in the validation analysis (n ¼ 203). In total, 78% of the blood samples were received for isoflavone analysis by 9 weeks after the completed SCG-FFQ had been returned, median: 6 weeks (I-QR 4-9 weeks).
Dietary assessment
The SCG-FFQ was sent by post to be self-completed by the subject. Guidelines for completing the questionnaire and photographic information on the size of portions were also included and advice on completing the SCG-FFQ was available by FreePhone.
The SCG-FFQ has been used extensively in Scotland (Sharp et al., 2002) and has been validated against 4-day weighed diet records for adequacy of macro and some micronutrient intakes (Masson et al., 2003) . It focused on dietary habit during the past 2-3 months and specified 155 food items accounting for 600 individual foods. For each of these food items, the respondent was asked to select from nine categories (ranging from 'Rarely/Never' to '7 days per week') the number of days per week the food item was eaten, and also to indicate their usual portion size by selecting from five categories (ranging from 1 to 5 þ measures per day). The SCG-FFQ also contained questions on the type and amount of vitamins, minerals and food supplements taken, on dietary change and special diets/dietary restrictions, and included a section for other foods eaten which the respondent had not already included elsewhere.
All SCG-FFQs were reviewed for completeness by checking for multiple frequency answers, unmarked portion sizes, and skipped food items. Participants were contacted by telephone or in person to complete or confirm information. Data from the reviewed SCG-FFQ were processed using the scanning software package TELEForm (version 5.2, Cardiff Software Inc., San Marcos, CA, USA) and software based on the Oracle Relational Database Management System (Version 7) which has been developed and routinely used at the University of Aberdeen. Intake estimates of specific nutrients and micronutrients were computed using McCance and Widdowson's The Compostition of Foods (5th edition) (Holland et al., 1991b) and related supplements (Holland et al., 1988 (Holland et al., , 1989 (Holland et al., , 1991a (Holland et al., , 1992a (Holland et al., , b, 1993 Chan et al., 1994 Chan et al., , 1995 Chan et al., , 1996 .
Food values for the isoflavones daidzein and genistein, were obtained from the newly constructed (Ritchie, 2004; Ritchie et al., 2005) and validated (Ritchie et al., 2004a) Isoflavone Food Database that contains isoflavone values for nearly 7000 foods and incorporates foods analysed by Liggins et al. (2000a, b) . Isoflavone contents were assigned to each of the 155 food items using the new database that incorporated isoflavone estimates for soy flour and protein added as bulking agents during food processing. Two specific soy food questions were also included that named the following foods as examples: (i) soya beans, textured vegetable protein (TVP), tofu and soya meat substitute, and (ii) nut roast, nut burgers and vegetable burgers. Soya milk and other soy-based foods reported in the 'Other Foods' section were also included in the assessment of isoflavone intake.
Blood sample collection and analysis Nonfasting blood samples were collected at the subjects' GP practice or by a research nurse. Peripheral blood (20 ml) was collected in a vacuum syringe using the Vacutainer s system and sent to the BioClin Laboratories, Cardiff, for analysis and storage.
Isotope dilution gas chromatography-mass spectrometry (GC-MS) was used to analyse the isoflavones genistein and daidzein, and the daidzein metabolite equol in serum (Morton et al., 1994) . Briefly, an isotopically-labelled analogue of the isoflavone analyte was added to the biological matrix, establishing an isotope ratio which determined ultimately the concentration of the analyte. The analyte and internal standard were extracted from the matrix, and purified by a chromatography step, the purified extract was then derivatised for GC-MS. The detection limit for each of the three assays was 0.1 mg/l (daidzein: 0.394 nmol/l, genistein: 0.370 nmol/l and equol: 0.417 nmol/l), data below these limits were regarded as zero (Morton et al., 2002) .
Statistical analysis
All statistical analyses were conducted with the SPSS package (version 11, SPSS Inc.). Univariate analysis was performed on estimated dietary intakes of isoflavones and total energy intake, isoflavonoid serum concentrations (genistein, daidzein and equol), and general anthropometric characteristics (including age, height, weight, body mass index (BMI) and basal metabolic rate (BMR) (Schofield, 1985) and the Energy Intake:BMR ratio (EI:BMR) ). As the distributions of serum isoflavone concentrations in the study population were markedly skewed, Spearman's rank correlations were calculated between isoflavone intake and the serum isoflavone concentrations. The level of agreement between the estimated isoflavone intake and serum concentrations was assessed by calculating the percentage of subjects categorised into the same and opposite thirds of isoflavone intake and serum concentration (high, medium and low isoflavone intake/serum concentration, based on the distribution within the subjects). The weighted Kappa statistic (Altman, 1991) was also calculated, the weightings used were 1 for complete agreement, that is, subjects classified into the same third, 0.5 for partial disagreement, that is, subjects differing by one category, and 0 for complete disagreement, that is, subjects differing by two categories.
Possible effects of low energy reporting were investigated by repeating the analysis omitting low-energy reporters (LERs) (i.e., those subjects not reported to be on a weight reducing diet whose EI:BMR was less than the cutoff value of 1.10, as defined by Black et al. (1991) ).
Results
Characteristics of the study population The age and anthropometric characteristics of the subjects are shown in Table 1 . These were similar to those characteristics of all the participants in the PCANDIET study (unpublished data) and are likely to be characteristic of the general Scottish male population within this age group, given the randomised selection of the controls.
Distribution of serum isoflavones and dietary intake
The distributions of isoflavonoid serum concentrations are shown in Table 2 . For each of the three isoflavonoids measured, the minimum values were below the level of detection. Owing to the extreme skewness of the data, medians are quoted.
Data for both equol and daidzein serum concentrations were missing for five subjects, whereas genistein serum concentration data was missing for seven subjects. The concentration of genistein (median 33.79 nmol/l, I-QR 14.12-64.93), the main component of the serum isoflavones, was nearly twice as high as that of daidzein (median 18.00 nmol/l, I-QR 8.26-29.45), the next largest component. Equol was detected in 98 subjects (49%) (median 0.67 nmol/l, I-QR 0.34-1.51). Overall, there was great interindividual variation in serum isoflavones, with a 270-fold variation between minimum and maximum values (1.62-435.01 nmol/l). The variation in estimated dietary intake of isoflavones (sum of daidzein and genistein) was even greater, from 0.01 to 8.3 mg/day (over 800-fold) with a median of 1.0 mg/day (I-QR 0.6-1.8). Table 3 shows the association between estimated isoflavone intake and isoflavonoid serum concentrations. Isoflavone intake was significantly correlated with serum concentrations for daidzein (r ¼ 0.24, 95% CI 0.11-0.36, P ¼ 0.001), genistein (r ¼ 0.26, 95% CI 0.12-0.38, Po0.001), daidzein and equol combined (r ¼ 0.24, 95% CI 0.11-0.37, P ¼ 0.001) and total isoflavonoids (r ¼ 0.27, 95% CI 0.13-0.39, Po0.001). Total energy intake and the EI:BMR ratio were also significantly correlated with isoflavone intake (r ¼ 0.33, 95% CI 0.20-0.44, Po0.001 and r ¼ 0.32, 95% CI 0.19-0.44, Po0.001, respectively). There was little or no change in the Spearman's rank correlation coefficients when the LERs were omitted (results not reported). The percentage of subjects correctly classified into the same third ranged from 39% (daidzein and equol combined) to 46% (genistein), whereas between 14% (daidzein and daidzein and equol combined) and 16% (total isoflavones) were grossly misclassified into the opposite third. Values of weighted Kappa ranged from 0.16 (P ¼ 0.002) for daidzein and equol combined to 0.22 (Po0.001) for genistein.
Relationship between dietary isoflavone intake and isoflavonoid serum concentrations
Discussion
In this study, a significant association between estimated isoflavone intake and serum isoflavonoid concentrations was observed.
Substantial between-subject variation was observed in both isoflavone intake and isoflavonoid serum concentrations. These large variations were expected and are comparable with between-subject variations reported in other isoflavone studies (Seow et al., 1998; Chen et al., 1999; Wakai et al., 1999; Arai et al., 2000; Huang et al., 2000; Uehara et al., 2000) , including those in Japanese and Chinese populations, who have been shown to have reasonably high and consistent isoflavone intakes (Chen et al., 1999; Arai et al., 2000) .
The median estimated isoflavone intake was 1.0 mg/day (I-QR 0.6-1.8), (mean 1.6 mg/day, 95% CI 1.4-1.8). This reported isoflavone intake is considerably lower than those reported in Japanese, Chinese and also Western vegetarian populations (who consume high levels of soy products) (Maskarinec et al., 1998; Seow et al., 1998; Chen et al., 1999; Giovannucci et al., 1999; Kirk et al., 1999; Arai et al., 2000; Huang et al., 2000; Uehara et al., 2000) , although none of these have focused on older men. Six recent studies have reported isoflavone intake within the UK. Clarke and Lloyd (2004) reported an average daily isoflavone intake of 3.3 mg, estimated from the Total Diet Study, with intake increasing to 10 mg/day within high consumers of isoflavone rich foods. This latter value is similar to the 10.5 mg/day reported in duplicate diets of vegetarians (Clarke et al., 2003) . In two smaller groups of male and female volunteers, Ritchie et al. (2004a, b) reported intakes averaging 3.7 mg/day and 11-12 mg/day, respectively. Mulligan et al. (2002) reported the only previously estimated mean isoflavone intakes in older men to be 0.76 mg/day. Although this is less than the median daily isoflavone intake estimated in this study, the order of magnitude is similar. The median serum concentration of total isoflavonoids was 51.49 nmol/l. Few other studies have assessed isoflavonoid concentrations in blood, preferring to measure concentrations in urine. Those studies that have, tended to use plasma rather than serum (Arai et al., 2000; Uehara et al., 2000; Verkasalo et al., 2001; Frankenfeld et al., 2002 Frankenfeld et al., , 2003 Ritchie et al., 2004b) , and none have reported results specifically in older men. Morton et al. (1997) reported mean daidzein and equol plasma concentrations in Scottish men to be 8.2 ng/ml and 0.57 ng/ml, respectively (which equates to 32.25 and 2.38 nmol/l). These are of similar magnitude to the mean daidzein and equol serum concentrations found in this study (26.66 and 1.05 nmol/l, respectively). Adlercreutz et al. (1993) also reported mean plasma concentrations for daidzein and genistein in Finnish men that were similar to those in this study, but many times lower than concentrations found in Japanese men (Adlercreutz et al., 1993; Yamamoto et al., 2001) .
Significant positive correlations between the estimated isoflavone intake and isoflavonoid serum concentrations were observed, with at least 39% of subjects being correctly classified into corresponding thirds. However, it should be noted that relatively low values of weighted Kappa were observed, suggesting only slight to fair agreement between estimated isoflavone intake and serum concentrations (according to Landis and Koch's, 1977 Kappa Interpretation Scale) . The Spearman rank correlation coefficients observed in this study were similar to a Japanese study (Yamamoto et al., 2001 ) that compared food-frequency questionnairebased intake data with serum concentrations in an epidemiological study similar to this. The observed correlation coefficients are lower than those reported in other isoflavone validation studies conducted in Western populations (r ¼ 0.45 to 0.92) (Verkasalo et al., 2001; Frankenfeld et al., 2002 Frankenfeld et al., , 2003 Ritchie et al., 2004a) . These differences are due, in all likelihood, to the combined effects of differences in study type (small lab-based rather than epidemiological); use of dietary assessment methods for individuals rather than populations (or use of duplicate diets); participants selected for high soy intakes and/or wide variation in intakes, and the tighter control over the juxtaposition of the blood sample and the dietary assessment. Regarding the latter point, the relatively fast metabolism of isoflavones (plasma half-lives for daidzein and genistein have been reported to be 5.8 and 8.4 h, respectively (Watanabe et al., 1998) ) makes the timing of blood samples of considerable importance. A single blood sample represents isoflavone intake only during the previous 10-12 h. Therefore, the standard method of using fasting blood samples may fail to accurately represent isoflavone intake. Whereas timed blood samples taken post consumption of meals, as used by Ritchie et al., 2004a , are more likely to represent daily isoflavone intake. Precise timing is very seldom possible in epidemiological studies so it is notable that significant positive correlations between assessed dietary intake and serum concentrations of isoflavones were found in this study population, which had a median intake of only 1 mg/day.
Isoflavone intake was derived mainly from 'hidden' and highly variable (Murphy et al., 1999) sources of soy -in processed and convenience foods that contain soy flour or soy protein as a cheap bulking agent (Horn-Ross et al., 2000a, b) . Only 7% of the study population reported consumption of specific soy foods. In addition to the systematic and random errors in both dietary intake and serum measurements, and the potential influence of genetic and physiological factors on the relationship between assessed intake and biomarker of a nutrient (Hunter, 1998) , for isoflavones this relationship is likely to be further influenced by gut micro-flora metabolism (Setchell 1998; Watanabe et al. 1998; Rowland et al., 1999 Rowland et al., , 2000 .
In conclusion, this study found that isoflavone intake estimated by the SCG-FFQ was significantly correlated with isoflavone serum concentrations, even in a population that does not regularly consume soy foods. Owing to the various factors mentioned that contribute to a weakening of the association between estimated dietary intake and biomarkers, the observed correlation between estimated isoflavone intake and serum concentrations can be interpreted as a lower limit for the true correlation between diet intake and the corresponding levels of biomarkers. It is therefore reasonable to conclude that in this age group of Scottish men, the SCG-FFQ is a valid tool for ranking subjects according to usual isoflavone intake in epidemiological studies.
